Zimoxin not checked

Jason Ahee, M.D.

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2/3 trial completes
Trials
14 active
15 in total · 14 in the EU

What this is

How it works
How it works isn't classified yet
Tested for
Endophthalmitis
Main trialPhase 2/3
“Intracameral injection of 0.1% moxifloxacin solution after cataract surgery to prevent endophthalmitis”In the company’s words, NCT03244072 on ClinicalTrials.gov
Other names
Moxifloxacin

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials15

TrialPhaseCompletesWhat it tests
Phase 2/3Not yet recruiting Oct 2030 Safety and Efficacy of Intracameral Zimoxin for Prevention of Endophthalmitis After Cataract Surgery
Phase 4Authorised not given Staphylococcus aureus Network Adaptive Platform trial (SNAP)
Phase 4Authorised not given Partial oral antibiotic treatment for bacterial brain abscess: An open-label randomised non-inferiority trial (ORAL)
Phase 4Authorised not given Oral Antibiotic Outpatient Therapy vs. Placebo in the Treatment of Uncomplicated Acute Appendicitis: a Randomized Double-blind Placebo-controlled Noninferiority Trial APPAC IV
Phase 2Authorised not given Finding the Optimal Regimen for Mycobacterium abscessus Treatment
Phase 4Authorised not given Early shift to oral antibiotic treatment of pyogenic vertebral osteomyelitis – a open label non-inferiority randomized nationwide study.
Phase 3Authorised not given Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia
Phase 3Authorised not given Efficacy and safety of different antimicrobial DURATions for the treatment of Infections associated with Osteosynthesis Material implanted after long bone fractures (DURATIOM). Phase 3 pragmatic multicenter open labelled randomized trial.
Phase 2Ended not given RANDOMIZED, CONTROLLED, OPEN, MULTICENTRIC CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A COMBINATION OF ANTI-TUBERCULOUS DRUGS BASED ON HIGH DOSE RIFAMPICIN, HIGH DOSE MOXIFLOXACIN AND LINEZOLID IN PATIENTS WITH BACILLIFEROUS PULMONARY TUBERCULOSIS (RML-TB).
Phase 3Authorised not given Feasibility of the Application of a new Six-month Treatment for multidrug-resistant tuberculosis (MDR-TB) patients in France (FAST-MDR)
Phase 4Authorised not given Optimizing the antibiotic treatment of uncomplicated acute appendicitis: a prospective randomized multicenter study
Phase 4Authorised not given Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia: A randomized, non-blinded, non-inferiority interventional study
Phase 4Authorised not given Acute appendicitis and microbiota – etiology and effects of the antimicrobial treatment - MAPPAC
Phase 4Authorised not given Rapid Oral Switch in Infectious Endocarditis, the ROSIE trial
Phase 4Authorised not given Early switch to oral antibiotic therapy in vertebral osteomyelitis: a multicentre, open-label, randomised, active control, parallel group, non-inferiority trial (sWITCH-VO)
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Zimoxin

Following is part of Solo: you see every change to Zimoxin the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in